Il y a eu 25 transactions d'initiés récentes enregistrées pour ArriVent BioPharma, Inc. Common Stock (AVBP), dont 11 achats et 9 ventes. Le total des achats d'initiés s'élève à $27.4M et le total des ventes d'initiés à $14.88M.
Les initiés notables ayant une activité récente comprennent Yao Zhengbin, Kung Winston, Kastenmayer James Paul. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — AVBP
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-02-02 |
Yao Zhengbin |
President and CEO |
Attribution de RSU |
550,000 |
$22.67 |
$12.47M |
550,000 |
| 2026-02-02 |
Kung Winston |
Chief Financial Officer |
Attribution de RSU |
140,000 |
$22.67 |
$3.17M |
140,000 |
| 2026-02-02 |
Kastenmayer James Paul |
General Counsel |
Attribution de RSU |
130,000 |
$22.67 |
$2.95M |
130,000 |
| 2026-02-02 |
Lachapelle Robin |
Chief Operating Officer |
Attribution de RSU |
130,000 |
$22.67 |
$2.95M |
130,000 |
| 2026-02-02 |
Lutzker Stuart |
President of R&d |
Attribution de RSU |
150,000 |
$22.67 |
$3.4M |
150,000 |
| 2025-12-10 |
Hillhouse Investment Management, Ltd. |
10 Percent Owner |
Vente Informative |
555,555 |
$23.37 |
$12.98M |
3,929,117 |
| 2025-07-11 |
Lachapelle Robin |
Chief Operating Officer |
Exercice d'Options (Vente) |
2,050 |
$2.28 |
$4.67K |
410 |
| 2025-06-18 |
Peterson Kristine |
Director |
Attribution de RSU |
15,502 |
$24.89 |
$385.84K |
15,502 |
| 2025-06-18 |
Hohneker John |
Director |
Attribution de RSU |
15,502 |
$24.89 |
$385.84K |
15,502 |
| 2025-06-18 |
Nolet Chris |
Director |
Attribution de RSU |
15,502 |
$24.89 |
$385.84K |
15,502 |
| 2025-06-18 |
Parsey Merdad |
Director |
Attribution de RSU |
15,502 |
$24.89 |
$385.84K |
15,502 |
| 2025-04-28 |
Parsey Merdad |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-04-28 |
Parsey Merdad |
Director |
Attribution de RSU |
28,346 |
$20.92 |
$593K |
28,346 |
| 2024-01-30 |
Orbimed Advisors Llc |
10 Percent Owner |
Conversion (Vente) |
469,615 |
- |
- |
- |
| 2024-01-30 |
Healy James |
Director |
Conversion (Vente) |
1,252,308 |
- |
- |
- |
| 2024-01-30 |
Gordon Carl L |
10 Percent Owner |
Conversion (Vente) |
821,827 |
- |
- |
- |
| 2024-01-30 |
Hillhouse Investment Management, Ltd. |
10 Percent Owner |
Conversion (Vente) |
4,761,903 |
- |
- |
- |
| 2024-01-25 |
Orbimed Advisors Llc |
10 Percent Owner |
Inconnu |
469,615 |
- |
- |
- |
| 2024-01-25 |
Healy James |
Director |
Inconnu |
1,252,308 |
- |
- |
- |
| 2024-01-25 |
Gordon Carl L |
10 Percent Owner |
Inconnu |
469,615 |
- |
- |
- |
| 2024-01-25 |
Hillhouse Investment Management, Ltd. |
10 Percent Owner |
Inconnu |
3,616,041 |
- |
- |
- |
| 2024-01-25 |
Kung Winston |
Chief Financial Officer |
Cession |
197,238 |
$7.76 |
$1.53M |
- |
| 2024-01-25 |
Nolet Chris |
Director |
Cession |
16,436 |
$6.24 |
$102.56K |
- |
| 2024-01-25 |
Kastenmayer James Paul |
General Counsel |
Cession |
32,873 |
$7.76 |
$255.09K |
- |
| 2024-01-25 |
Nolet Chris |
Director |
Attribution de RSU |
17,884 |
$18.00 |
$321.91K |
17,884 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
